THE Department of Agriculture (DA) said it may soon allow pork imports from parts of Germany that are free from African Swine Fever (ASF) instead of blanket bansTHE Department of Agriculture (DA) said it may soon allow pork imports from parts of Germany that are free from African Swine Fever (ASF) instead of blanket bans

German pork import regionalization scheme expected to be in place within three months

2026/03/02 00:01
2 min read
For feedback or concerns regarding this content, please contact us at [email protected]

THE Department of Agriculture (DA) said it may soon allow pork imports from parts of Germany that are free from African Swine Fever (ASF) instead of blanket bans on all German pork once an outbreak is detected.

Agriculture Undersecretary for Livestock Constante J. Palabrica told reporters that Germany’s application for ASF regionalization could be completed and approved within the next three months.

Mr. Palabrica said Germany first applied for regionalization status two years ago, but the process has been slow due to the rigorous document review conducted by the Bureau of Animal Industry (BAI).

“We require a lot of paperwork and are very strict with the documents. That’s why Germany has yet to be given regionalization status,” he said on the sidelines of the International Farmers Summit in Pasay City.

Mr. Palabrica said delays often stem from slow responses from Germany.

Last year, the DA formally adopted ASF regionalization rules, under which pork products must originate from ASF-free regions, be transported in sealed vehicles directly to approved slaughterhouses, and pass both ante- and post-mortem inspections.

German pork imports were first suspended in 2019 after meat from ASF-affected Poland was found in German shipments.

A subsequent ban was enforced in 2020 after Germany reported its first official ASF case in a wild boar.

Live swine must also come from ASF-free zones, show no clinical signs of infection, and avoid restricted areas during transport.

Once the application is cleared, both countries must sign a bilateral agreement outlining specific animal health requirements.

Other major exporters like Poland, Russia, and Canada have obtained regionalization approval from the Philippines. — Vonn Andrei E. Villamiel

Market Opportunity
PepeFork Logo
PepeFork Price(PORK)
$0.00000001905
$0.00000001905$0.00000001905
-0.52%
USD
PepeFork (PORK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09